Cen WC - Search Results

1

Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage.

Su S, Ye MF, Cai XT, Bai X, Huang ZH, Ma SC, Zou JJ, Wen YX, Wu LJ, Guo XJ, Zhang XL, Cen WC, Su DH, Huang HY, Dong ZY. Su S, et al. Among authors: cen wc. BMC Med. 2021 Dec 20;19(1):322. doi: 10.1186/s12916-021-02194-z. BMC Med. 2021. PMID: 34923987 Free PMC article.

2

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.

Ye MF, Su S, Huang ZH, Zou JJ, Su DH, Chen XH, Zeng LF, Liao WX, Huang HY, Zeng YY, Cen WC, Zhang XL, Liao CX, Zhang J, Zhang YB. Ye MF, et al. Among authors: cen wc. Ann Transl Med. 2020 Sep;8(18):1143. doi: 10.21037/atm-20-5964. Ann Transl Med. 2020. PMID: 33240992 Free PMC article.

3

The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.

Li L, Zhang H, Xie Y, Su N, Su S, Zhang X, Cen W. Li L, et al. Comput Math Methods Med. 2022 Feb 25;2022:1475871. doi: 10.1155/2022/1475871. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Nov 1;2023:9789208. doi: 10.1155/2023/9789208 PMID: 35251294 Free PMC article. Retracted. Clinical Trial.

4

Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer.

Su S, Lin A, Luo P, Zou J, Huang Z, Wang X, Zeng Y, Cen W, Zhang X, Huang H, Hu J, Zhang J. Su S, et al. Ann Transl Med. 2021 Sep;9(18):1475. doi: 10.21037/atm-21-4543. Ann Transl Med. 2021. PMID: 34734027 Free PMC article.

5

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing.

Su S, Zou JJ, Zeng YY, Cen WC, Zhou W, Liu Y, Su DH, Zhang XL, Huang HY, Lei A, Huang ZH, Jin Y, Li L, Su N, Xie YL, Zhao ZG, Liu JX. Su S, et al. Among authors: cen wc. Biomed Res Int. 2019 Nov 6;2019:6096350. doi: 10.1155/2019/6096350. eCollection 2019. Biomed Res Int. 2019. PMID: 31781628 Free PMC article.

6

Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.

Zou J, Su S, Chen Z, Liang F, Zeng Y, Cen W, Zhang X, Xia Y, Huang D. Zou J, et al. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3456-3464. doi: 10.1080/21691401.2019.1626863. Artif Cells Nanomed Biotechnol. 2019. PMID: 31469318 Free article.

7

Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor.

Xie Y, Su N, Zhou W, Lei A, Li X, Li W, Huang Z, Cen W, Hu J. Xie Y, et al. Cancer Manag Res. 2021 Oct 1;13:7517-7526. doi: 10.2147/CMAR.S326349. eCollection 2021. Cancer Manag Res. 2021. PMID: 34621133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters